Other languages Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Market Closed - Deutsche Boerse AG Other stock markets 10:47:22 2024-05-31 EDT			5-day change	1st Jan Change
9.62 ^EUR	+4.57%		+1.26%	-3.06%

05-23	Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America	MT
04-29	Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3%	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America	05-22
Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3%	04-28
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors	03-28
Clinuvel Pharmaceuticals Launches Share Buyback Program	03-14
Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16	03-13
Clinuvel Pharmaceuticals Limited announces an Equity Buyback for 1,500,000 shares, representing 2.99% of its issued share capital.	03-13
Clinuvel Pharmaceuticals Limited authorizes a Buyback Plan.	03-13
Malibu shines a light on CLINUVEL’s pioneering work in photomedicine	03-04
Clinuvel Reports Positive Results in SCENESSE Study	03-03
Transcript : Clinuvel Pharmaceuticals Limited, H1 2024 Earnings Call, Feb 22, 2024	02-22
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-21
Clinuvel Pharmaceuticals Limited Announces Change to Registered Office	12-06
Clinuvel Doses First Patient in Phase 3 Trial of Vitiligo Treatment	23-10-18
Transcript : Clinuvel Pharmaceuticals Limited - Special Call	23-10-01
Clinuvel Pharmaceuticals Limited Announces Board Changes	23-09-28
Clinuvel Pharmaceuticals Teams Up With Vitiligo Experts to Assess Scenesse	23-09-13
Ex-dividend day for final dividend	23-09-04	FA
Transcript : Clinuvel Pharmaceuticals Limited, 2023 Earnings Call, Aug 29, 2023	23-08-29
Clinuvel Pharmaceuticals Limited Announces Dividend for the Full Year Ended June 30, 2023, Payable on September 20, 2023	23-08-28
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Other languages

Filters